Caution should be exercised when ciprofloxacin or potent CYP1A2 inhibitors (e. g. fluvoxamine) are combined with erlotinib.
Debe tenerse precaución cuando ciprofloxacino o inhibidores potentes del CYP1A2 (por ej. fluvoxamina) se combinen con erlotinib.